These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 31338903)
1. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer. Feng W; Zong W; Li Y; Shen X; Cui X; Ju S J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903 [TBL] [Abstract][Full Text] [Related]
2. Serum level of long noncoding RNA B3GALT5-AS1 as a diagnostic biomarker of colorectal cancer. Ding Y; Feng W; Ge JK; Dai L; Liu TT; Hua XY; Lu X; Ju SQ; Yu J Future Oncol; 2020 May; 16(13):827-835. PubMed ID: 32207329 [No Abstract] [Full Text] [Related]
3. Highly expressed B3GALT5-AS1 contributes to gastric cancer progression by recruiting WDR5 to mediate B3GALT5 and regulating β-catenin/ZEB1 axis. Feng W; Tang Y; Jing R; Ju S; Zong W J Cell Mol Med; 2024 Sep; 28(17):e70061. PubMed ID: 39224045 [TBL] [Abstract][Full Text] [Related]
4. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer. Li W; Li N; Kang X; Shi K Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690 [TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer. Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090 [TBL] [Abstract][Full Text] [Related]
6. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer. Liu W; Li Y; Zhang Y; Shen X; Su Z; Chen L; Cai W; Wang F; Ju S Pathol Res Pract; 2020 Jan; 216(1):152757. PubMed ID: 31785996 [TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer. Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391 [TBL] [Abstract][Full Text] [Related]
8. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203. Wang L; Wei Z; Wu K; Dai W; Zhang C; Peng J; He Y Aging (Albany NY); 2018 Dec; 10(12):3662-3682. PubMed ID: 30530918 [TBL] [Abstract][Full Text] [Related]
10. LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric cancer. Li Y; Wen X; Wang L; Sun X; Ma H; Fu Z; Li L Surg Oncol; 2017 Dec; 26(4):527-534. PubMed ID: 29113674 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999 [TBL] [Abstract][Full Text] [Related]
12. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer. Shi XY; Sun YZ; Li M; Li HY Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606 [TBL] [Abstract][Full Text] [Related]
13. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression. Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427 [TBL] [Abstract][Full Text] [Related]
14. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer. Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer. Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway. Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821 [TBL] [Abstract][Full Text] [Related]
17. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer. Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221 [TBL] [Abstract][Full Text] [Related]
18. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer. El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293 [TBL] [Abstract][Full Text] [Related]
19. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer. Feng Y; Zhang Q; Wang J; Liu P Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer. Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]